EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study

Malin Enblad, Lana Ghanipour, Gabriella Palmer, Valentinus Valdimarsson, Elinor Bexe Lindskog, Peter Cashin

European Journal of Surgical Oncology · 2025

DOI: 10.1016/j.ejso.2025.110429 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2025. Verfasst von Malin Enblad und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala University Hospital, Uppsala, 751 85, Sweden. Electronic address: ma…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Carcinoma, Signet Ring Cell, Colorectal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bengt Ihre's fund, Uppsala University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Signet ring cell (SRC) colorectal cancer is strongly associated with peritoneal metastases (PM), but the role of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains uncertain due to poor prognosis. This study aimed to analyse the prognostic impact of SRCs, assess clinical characteristics, and evaluate the risk of open-close laparotomy. METHODS: This Swedish population-based study included patients with colorectal PM accepted for initial CRS and HIPEC at four national centres between 2010 and 2023. Data were retrieved from the Swedish HIPEC registry. Tumours with ≥50 % and

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsCarcinoma, Signet Ring CellColorectal NeoplasmsHumansFemaleMaleSwedenMiddle AgedPrognosisAgedHyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresSurvival RateAdultLaparotomyRegistriesLymphatic Metastasis

Stichwörter der Autor:innen

Colorectal cancerCytoreductive surgeryHIPECPeritoneal metastasesSignet ring cells

Autor:innen und Institutionen

  • Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala University Hospital, Uppsala, 751 85, Sweden. Electronic address: malin.enblad@surgsci.uu.se.
  • Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala University Hospital, Uppsala, 751 85, Sweden.
  • Department of Molecular Medicine and Surgery, Karolinska Institutet, and Department of Pelvic Cancer, GI Oncology and Colorectal Surgery Unit, Karolinska University Hospital, Stockholm, 171 76, Sweden.
  • Department of Clinical Sciences, Lund University, Skåne University Hospital, Malmö, 205 02, Sweden.
  • Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, 413 45, Sweden; Region Västra Götaland, Sahlgrenska University Hospital, Department of Surgery, Gothenburg, 413 45, S…

Förderung

  • Bengt Ihre's fund
  • Uppsala University Hospital

Zitieren

APA

Enblad, M., Ghanipour, L., Palmer, G., Valdimarsson, V., Bexe Lindskog, E., & Cashin, P. (2025). Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study. European Journal of Surgical Oncology. https://doi.org/10.1016/j.ejso.2025.110429

Vancouver

Enblad M, Ghanipour L, Palmer G, Valdimarsson V, Bexe Lindskog E, Cashin P. Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study. European Journal of Surgical Oncology. 2025. doi:10.1016/j.ejso.2025.110429

BibTeX
@article{Enblad2025,
  author = {Enblad, Malin and Ghanipour, Lana and Palmer, Gabriella and Valdimarsson, Valentinus and Bexe Lindskog, Elinor and Cashin, Peter},
  title = {Prognosis and clinical characteristics of signet ring cell colorectal peritoneal metastases – a Swedish population-based study},
  journal = {European Journal of Surgical Oncology},
  year = {2025},
  doi = {10.1016/j.ejso.2025.110429}
}
Kostenlos starten →